Work

Response to ONC201 by Prior Radiotherapy Regimen in Recurrent H3 K27M-Mutant Diffuse Midline Glioma

Year: 2024

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2024.07.487

Authors: I. Arrillaga-Romany, S.L. McGovern, J.E. Allen, S. Gardner, A.M. Haggiagi, Y. Odia, S.C. Ramage, P.Y. Wen

Institutions: Massachusetts General Hospital, The University of Texas MD Anderson Cancer Center, Chimerix (United States), New York University, Columbia University Irving Medical Center, Florida International University, Center for Neuro-Oncology, Dana-Farber Cancer Institute

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Gilead Sciences, Varian Medical Systems, Novocure, Akebia Therapeutics, National Cancer Institute

OpenAlex ID: W4402945499

FWCI:

Cites:

Cited by:

Related to: 10